Slade Managing Director, David Slade says the purchase of mobiLIFE’s antibiotic compounding arm adds to Slade Health’s current compounding and TGA-licensed facilities.
“This is an exciting time for Slade. We are constantly looking at new and innovative ways to deliver a comprehensive compounding service and the addition of antibiotic compounding means we can offer a complete service to our customers and subsequently their patients,” he said.
Slade Health will also be the distributor for the mobiFUSER, a safe and effective at-home care infusion pump. The mobiFUSER infusion device delivers medication on a continuous basis over a specified period of time and is ideal for 24 hour intravenous antibiotics.